Fabricator: Dragon Pharma, Europe
Unit: 1 x 10 ml
Strength: 400 mg/ml
If your order hasnt arrived within 35 days after shipping, we will resend it for free.
Overview of Testosterone Enanthate 400mg profile, dosage range, cycle and key androgenic properties.
Dragon Pharma Enantat 400 is a high-concentration Testosterone Enanthate formulation delivering 400 mg of active testosterone per mL — 60% more hormone per injection volume than standard 250 mg/mL preparations. It is the advanced-user evolution of the Dragon Pharma Enantat 250, engineered for performance-focused protocols where dosing efficiency, injection volume reduction, and stable supraphysiologic androgen levels are the priority.
Testosterone Enanthate is the most widely used long-acting testosterone ester in both clinical medicine and bodybuilding. It is the foundational compound of virtually every anabolic steroid cycle — the hormonal backbone around which all other compounds are organized. Its balanced anabolic-to-androgenic ratio of 100:100 makes it simultaneously one of the most potent and most predictable compounds available, with a side effect profile that is thoroughly understood and manageable with proper on-cycle support.
At 400 mg/mL, Dragon Pharma Enantat 400 allows intermediate and advanced users to achieve their target weekly dose using significantly less injection volume. A 600 mg/week protocol, for example, requires just 1.5 mL of Enantat 400 versus 2.4 mL of a standard 250 mg/mL preparation — a practical advantage for high-dose cycles.
Independent laboratory testing of Dragon Pharma Enantat 400 (batch verified 2025.10.02) confirmed an actual concentration of 418 mg/mL — 104.5% of label claim — verifying pharmaceutical-grade potency and manufacturing precision.
The core compound is identical — Testosterone Enanthate. The difference is concentration and who the product is designed for.
| Feature | Enantat 250 | Enantat 400 |
|---|---|---|
| Concentration | 250 mg/mL | 400 mg/mL |
| Volume for 500 mg/week dose | 2.0 mL | 1.25 mL |
| Volume for 750 mg/week dose | 3.0 mL | 1.875 mL |
| Injection comfort | Standard | May require warming (high-concentration) |
| Target user | Beginner–Intermediate | Intermediate–Advanced |
| MCT carrier oil | Yes | Yes |
| Lab verified | Yes - Enantat 250 lab test | Yes — 418 mg/mL confirmed |
The choice between Enantat 250 and Enantat 400 is primarily based on weekly dosage, injection volume preference, and cycle structure. The active compound is identical — Testosterone Enanthate — so differences are purely practical.
If your weekly testosterone dose is below 500 mg, Enantat 250 is the cleaner and more comfortable choice.
If you're running 500 mg/week or above, Enantat 400 becomes more practical by reducing injection volume, minimizing the number of vials required over a long cycle, and simplifying administration at higher doses.
Higher concentration products allow users to inject less liquid to achieve the same dose. This can reduce injection frequency-related discomfort and make higher-dose protocols more manageable over extended cycles.
Preparations at 400 mg/mL or above may cause increased post-injection discomfort (PIP) in some users due to higher solvent concentration.
To reduce discomfort:
Testosterone Enanthate delivers free testosterone through a slow-release depot mechanism. After intramuscular injection into the lipid phase, esterases in the bloodstream gradually cleave the enanthate ester from the testosterone molecule, releasing free testosterone over the active window.
Free testosterone binds to androgen receptors on muscle cells, triggering genomic signaling that directly upregulates:
Testosterone antagonizes cortisol — the primary catabolic hormone. Elevated free testosterone suppresses cortisol's catabolic signaling, protecting lean mass during caloric deficits, high-volume training phases, and recovery periods.
Testosterone increases erythropoietin (EPO) secretion, stimulating red blood cell production and raising hematocrit. Higher oxygen-carrying capacity translates to improved endurance, faster recovery between sets, and reduced training-induced fatigue — compounding gains over the length of a cycle.
Supraphysiologic testosterone levels suppress the hypothalamic-pituitary-testicular axis (HPTA), reducing LH and FSH secretion and pausing endogenous testosterone production. This suppression is dose-dependent and proportional — higher doses produce deeper and faster suppression. Full HPTA recovery after a high-dose Enantat 400 cycle requires a well-structured PCT protocol.
At supraphysiologic doses, Testosterone Enanthate drives substantial lean mass accumulation through elevated protein synthesis rates and sustained nitrogen retention. Clinical dose-response research (Bhasin et al., 1996; 2001) confirmed a direct linear relationship between testosterone dose and fat-free mass gains — the higher the dose, the greater the anabolic response, up to and beyond 600 mg/week.
Intermediate users running Enantat 400 at 400–600 mg/week over 12–16 weeks in a structured bulking cycle with appropriate nutrition typically gain 7–12 kg of combined lean mass and intracellular fluid — with keepable lean tissue representing a significant fraction of that after water loss at cycle end.
Higher androgen levels dramatically improve neuromuscular efficiency, force production capacity, and the rate of strength development. Users commonly report compound lift increases of 20–40 kg over a 12–16 week Enantat 400 cycle — with strength gains beginning to manifest as blood levels stabilize in weeks 3–4.
Testosterone's effects on satellite cell activation, protein synthesis speed, and anti-cortisol signaling substantially reduce inter-session recovery time. Advanced users running Enantat 400 can support higher training frequencies and greater overall weekly volumes — a compounding performance advantage over the full cycle length.
Supraphysiologic testosterone produces well-documented improvements in libido, sexual performance, motivation, drive, and overall psychological energy. Many users report that the subjective quality-of-life effects of a testosterone cycle are among the most immediately noticeable changes — typically appearing within the first 2–3 weeks as blood levels climb.
The long enanthate ester provides stable, sustained testosterone release between injections. Once- or twice-weekly dosing maintains consistent blood levels without the sharp peaks and troughs associated with short-acting esters, reducing hormonal fluctuation and its associated side effects.
The Enantat 400 concentration is specifically suited to performance dosing rather than therapeutic replacement. This distinction is important from both a health and regulatory perspective.
The Endocrine Society's Clinical Practice Guidelines for male hypogonadism define the following therapeutic targets:
| Parameter | Therapeutic TRT |
|---|---|
| Injectable dose | 75–200 mg/week |
| Target serum testosterone | 400–700 ng/dL (mid-normal physiologic range) |
| Goal | Restore deficiency — not maximize anabolism |
| Monitoring | Serum testosterone, hematocrit, PSA, clinical review every 3–6 months |
At therapeutic doses, confirmed hypogonadal men experience meaningful improvements in lean mass, fat mass, libido, energy, and cognitive function — but on a timescale of months, with more modest changes compared to performance dosing.
| Experience Level | Weekly Dose | Cycle Length | Key Notes |
|---|---|---|---|
| Intermediate | 400–600 mg/week | 12–16 weeks | Second or third cycle; requires AI management |
| Advanced | 600–800 mg/week | 14–20 weeks | Full bloodwork essential; experienced with side effects |
| High-dose protocols | 800+ mg/week | 12–16 weeks | Significant cardiovascular and endocrine demands |
Acne and oily skin: More common in genetically predisposed individuals; dose-dependent.
Accelerated male pattern baldness: Driven by DHT conversion; depends on genetic susceptibility.
Increased body / facial hair: Androgenic effect; varies by dose and individual response.
Prostate stimulation: Monitor PSA in older users; avoid use in active prostate conditions.
High-dose testosterone suppresses the HPTA rapidly and significantly. Natural testosterone production typically shuts down within 1–2 weeks of starting a cycle.
Without PCT, recovery may take 3–6 months or longer. Symptoms of incomplete recovery include low libido, fatigue, depression, erectile dysfunction, and loss of strength and muscle mass.
HDL cholesterol reduction: Dose-dependent; regular lipid panel monitoring every 6–8 weeks is recommended.
Elevated hematocrit: Increased red blood cell count raises blood viscosity; blood donation may be considered if levels exceed 52–54%.
Blood pressure elevation: Primarily driven by water retention and estrogen imbalance; managed via estrogen control and lifestyle factors.
Left ventricular hypertrophy: Risk increases with prolonged supraphysiologic use and inadequate cardiovascular management.
Liver toxicity: Injectable testosterone is not hepatotoxic at typical doses unless combined with oral hepatotoxic compounds.
Kidney damage: Not a direct pharmacological effect of testosterone enanthate.
Immediate mood disorder: Mood changes are dose-dependent and vary widely between individuals; severe psychiatric effects are uncommon at controlled doses.
liCT should begin 14–18 days after the last injection to allow ester clearance before SERM use.
Testosterone Enanthate at performance doses carries a well-documented side effect profile. Enantat 400 produces the same effects as any Testosterone Enanthate product — the higher concentration affects volume-per-injection, not the pharmacological activity of the hormone itself.
Testosterone Enanthate aromatizes into estradiol via the aromatase enzyme. At performance doses, this aromatization is significant and must be actively managed.
| Side Effect | Cause | Management |
|---|---|---|
| Water retention / bloating | Elevated estradiol | AI: Aromasin 12.5 mg EOD or Anastrozole 0.5 mg EOD |
| Gynecomastia | Estradiol action on breast tissue | AI + Nolvadex (SERM) if active gyno develops |
| High blood pressure | Fluid retention + vascular changes | AI management; Tadalafil (Cialis); cardiovascular monitoring |
Avoid over-suppressing estrogen. Estradiol plays critical roles in libido, joint lubrication, bone density, and mood regulation. Target optimal management — not elimination.
Acne and oily skin are more likely in genetically predisposed individuals and are generally dose-dependent. Accelerated male pattern baldness occurs due to DHT conversion and typically requires a genetic predisposition. Increased body and facial hair growth is an androgenic effect that varies based on dose and individual sensitivity. Prostate stimulation may occur, so PSA should be monitored in older users, and use is contraindicated in individuals with active prostate conditions.
High-dose testosterone suppresses the HPTA quickly and deeply. Natural testosterone production ceases within 1–2 weeks of beginning a performance cycle. Without PCT, recovery can take 3–6 months or longer.
Symptoms of failed recovery include: low libido, fatigue, depression, erectile dysfunction, and significant muscle and strength loss.
HDL cholesterol reduction is a dose-dependent risk, so lipid panels should be monitored every 6–8 weeks during a cycle. Elevated hematocrit occurs due to increased red blood cell production, which raises blood viscosity; blood donation may be considered if hematocrit exceeds 52–54%. Blood pressure elevation is primarily driven by water retention and is typically managed through proper estrogen control. Left ventricular hypertrophy risk increases with prolonged supraphysiologic use and insufficient cardiovascular management.
| Concern | Reality |
|---|---|
| Liver toxicity | Injectable testosterone has no hepatotoxic effect — no liver support required unless stacking hepatotoxic orals |
| Kidney damage | Not a direct pharmacological effect at typical performance doses |
| Immediate mood disorder | Mood changes are dose-dependent; severe psychiatric effects are associated with extreme doses and individual vulnerability |
| Support Category | Compound | Purpose |
|---|---|---|
| Aromatase inhibitor | Aromasin (Exemestane) or Anastrozole | Estrogen management — essential |
| SERM (PCT / anti-gyno) | Nolvadex (Tamoxifen) | Gynecomastia prevention; PCT core compound |
| LH/FSH restoration (PCT) | Clomid (Clomiphene) | Restores endogenous testosterone production |
| Testicular recovery (pre-PCT) | HCG 500–1000 IU EOD × 10 days | Accelerates testicular reactivation before PCT |
| Blood pressure / vascularity | Cialis (Tadalafil 20mg) | Manages BP; enhances pump and vascularity on cycle |
| Cardiovascular support | Omega-3 fatty acids, CoQ10 | Lipid profile and heart health support |
| Liver support (if adding orals) | TUDCA or NAC | Hepatoprotection when stacking oral AAS |
Begin PCT 14–18 days after your last Enantat 400 injection. This delay allows the long enanthate ester to clear before introducing SERMs.
Standard PCT Protocol
Optional pre-PCT: HCG 500–1000 IU EOD for 10 days before starting Nolvadex/Clomid.| Week | Nolvadex | Clomid |
|---|---|---|
| Week 1–2 | 40 mg/day | 100 mg (days 1–2), then 50 mg/day |
| Week 3–4 | 20 mg/day | 25 mg/day |
| Week | Nolvadex | Clomid |
| Week 1–2 | 40 mg/day | 100 mg/day |
| Week 3–4 | 20 mg/day | 50 mg/day |
| Week 5–6 | 10 mg/day | 25 mg/day |
The Enantat 400 intermediate bulking cycle is the most commonly used Testosterone Enanthate protocol, designed to support steady lean muscle gains, strength progression, and overall performance improvement over an extended training phase.
This setup can be run as a standalone testosterone cycle or combined with an oral kickstart depending on experience level and physique goals.
| Compound | Dragon Pharma Enantat 400 (solo or oral kickstart option) |
| Weekly Dose | 400–600 mg |
| Injection Schedule | 200–300 mg Monday + 200–300 mg Thursday |
| Cycle Length | 12–16 Weeks |
| Estrogen Management | Aromasin 12.5 mg EOD or Anastrozole 0.5 mg EOD (from week 2) |
| PCT Start | 14–18 days after last injection |
The advanced mass stack combines long-ester testosterone with Dragon Pharma nandrolone to create a strong anabolic environment focused on significant muscle gain, strength development, and overall mass accumulation over an extended cycle period.
This protocol is generally used by experienced users due to its increased hormonal load and requirement for structured monitoring and support strategies.
| Compounds | Enantat 400 + Deca 300 (Nandrolone Decanoate) |
| Weekly Doses | Testosterone 600 mg/week + Deca 400 mg/week |
| Cycle Length | 16–20 Weeks |
| Kickstart Option | Dianabol 30–50 mg/day for first 4 weeks |
| Support Protocol | AI (estrogen control) + Cabergoline (prolactin management for Deca) + cardiovascular monitoring |
The lean mass and recomposition stack combines Testosterone Enanthate with Dragon Pharma Boldenone to support steady lean muscle gains, improved conditioning, and enhanced vascularity with relatively controlled water retention.
This protocol is typically used during longer training phases where the goal is a gradual improvement in body composition rather than rapid bulk gain.
| Compounds | Enantat 400 + Boldenone 300 |
| Doses | Testosterone 400–500 mg/week + Boldenone 400–600 mg/week |
| Cycle Length | 14–16 Weeks |
| Profile | Lean, dry gains with increased vascularity and appetite |
| Support | Mild AI; monitor hematocrit (both compounds may increase red blood cell count) |
The advanced strength and power stack combines Testosterone Enanthate with Dragon Pharma Trenbolone Enanthate to create a highly potent anabolic environment focused on maximum strength, muscle density, and fat reduction over a relatively short, intensive cycle.
This protocol is typically reserved for experienced users due to its strong systemic effects and the need for structured monitoring and support strategies throughout the cycle.
| Compounds | Enantat 400 + Trenbolone 200 |
| Doses | Testosterone 400–500 mg/week + Trenbolone 300–400 mg/week |
| Cycle Length | 12–14 Weeks |
| Profile | Extreme muscle density, strength gains, and pronounced fat mobilization with minimal water retention |
| Support | AI (estrogen control); prolactin management strategies; intensive cardiovascular monitoring |
Understanding where Enantat 400 sits relative to other testosterone forms helps with cycle planning and ester selection.
| Feature | Enantat 400 | Propionat 100 | Cypionat 250 | Suspension 100 |
|---|---|---|---|---|
| Half-life | ~5–6 days | ~2 days | ~7–8 days | Hours |
| Active Life | ~15–16 days | ~4–5 days | ~14–16 days | <1 day |
| Injection Frequency | Every 5–7 days | Every other day | Every 7 days | Daily |
| Onset Speed | Moderate (1–2 weeks) | Fast (2–3 days) | Moderate (1–2 weeks) | Immediate |
| Blood Level Stability | High | Moderate | High | Low |
| Water Retention Risk | Moderate–High | Low–Moderate | Moderate–High | Moderate |
| Injection Convenience | High | Low | High | Very Low |
| Best Use Case | Bulking / advanced base compound | Cutting / fast-start / pre-contest | TRT / bulking / beginner-friendly | Pre-contest / short bursts |
| User Level | Intermediate–Advanced | Intermediate | Beginner–Advanced | Advanced only |
| Dragon Pharma Product | Enantat 400 | Propionat 100 | Cypionat 250 | Suspension 100 |
Everything you need to know about the Enantat 400
Testosterone enanthate 400 is commonly prescribed for testosterone replacement therapy (TRT) to treat low testosterone levels. It may also support improvements in energy, mood, muscle mass, and overall health when used appropriately.
It has a half-life of around 4 - 5 days, but its effects can last for several weeks. Most protocols use injections every 5 - 7 days to maintain stable hormone levels.
Some users notice improved mood and energy within a few weeks, while physical changes like muscle growth and fat loss typically take several weeks to become noticeable.
Typical TRT dosages range from 50 mg to 200 mg per week, depending on individual needs, lab results, and medical guidance.
Possible side effects include acne, increased red blood cell count, hormonal suppression, and changes in cholesterol. Monitoring helps manage these risks.
In medical TRT, PCT is not required because treatment is ongoing. Outside of medical use, recovery protocols is needed after discontinuation. Use Clomid after last injection
Yes, It is a prescription-only medication in most countries.
Sustanon 270 contains multiple esters for mixed release speeds, while Enantat 400 uses a single long ester with simpler dosing and more predictable release.
It is administered through intramuscular injection, typically in the glute or thigh, using sterile technique.
Both are long-acting forms of testosterone with similar effects. Cypionat 250 by Dragon Pharma has a slightly longer half-life, which may allow for less frequent injections.
Proper handling and preservation guidelines.
Enantat 400 (Testosterone Enanthate) should be stored at room temperature (around 20 25 °C) in a dry, dark place, away from direct sunlight and heat.
Keep the vial tightly sealed and protected from moisture to maintain its stability and sterility.
Avoid refrigerating or freezing it, as temperature extremes can affect the solution’s consistency.
I like this site, i often receive gift from them. The last order was 5 dragon pharma enantat 400 and received one for free
Works great exactly what I was expecting
Please log in to write Enantat 400 review.
Order Includes:
Order Includes:
July 7, 2026
the same, I ordered 7 vials of Test E 400, and everything arrived well packaged and exactly as described. As a nice surprise, they also included a free gift of 4 Cialis tablets.